Developing novel drugs by in vivo imaging of the CNS

Rueger, Marie Adele; Kracht, Lutz; Thiel, Alexander; Hilker, Rüdiger; Herholz, Karl; Winkeler, Alexandra; Thomas, V. A.; Heneka, M.; Sobesky, Jan; Graf, Rudolf; Heiss, Wolf-Dieter; Jacobs, Andreas H.

Lokale TagsFreigabegeschichteDetailsÜbersicht

Developing novel drugs by in vivo imaging of the CNS

Rueger, M. A., Kracht, L., Thiel, A., Hilker, R., Herholz, K., Winkeler, A., et al. (2007). Developing novel drugs by in vivo imaging of the CNS. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 51(2), 164-181.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D3C9-7 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D3CA-5

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Rueger, Marie Adele, Autor
Kracht, Lutz¹, Autor
Thiel, Alexander¹, Autor
Hilker, Rüdiger, Autor
Herholz, Karl², Autor
Winkeler, Alexandra³, Autor
Thomas, V. A., Autor
Heneka, M., Autor
Sobesky, Jan¹, Autor
Graf, Rudolf⁴, Autor
Heiss, Wolf-Dieter², Autor
Jacobs, Andreas H.³, Autor

Affiliations:
1Klinisches PET, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149663
2Wolf-Dieter Heiss, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149649
3Gentherapie und Molekulare Bildgebung, Neurologische Abteilung, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149662
4Multimodal Imaging of Brain Metabolism, Research Groups, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149667